Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 10Completed 4Unknown 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 4NIH 4

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 4354Neoplasms 3056Prostatic Neoplasms 1904Colorectal Neoplasms 1739Lung Neoplasms 1555Carcinoma, Non-Small-Cell Lung 1270Pancreatic Neoplasms 981Leukemia, Myeloid, Acute 952Multiple Myeloma 951Lymphoma 912Head and Neck Neoplasms 894Leukemia 852Precursor Cell Lymphoblastic Leukemia-Lymphoma 833Neoplasm Metastasis 793Colonic Neoplasms 785Carcinoma, Hepatocellular 762Ovarian Neoplasms 757Melanoma 752Stomach Neoplasms 742Rectal Neoplasms 701Brain Neoplasms 696Lymphoma, Non-Hodgkin 663Leukemia, Lymphocytic, Chronic, B-Cell 618Uterine Cervical Neoplasms 607Lymphoma, Follicular 559Glioblastoma 541Recurrence 539Hodgkin Disease 532Esophageal Neoplasms 527Myelodysplastic Syndromes 508

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × OTHER × Li-Fraumeni Syndrome × Clear all
NCT04966923 2022-08-09

BREAST-TP53

Instituto do Cancer do Estado de São Paulo

Completed
135 enrolled
Breast

Breast Neoplasms, Li-Fraumeni Syndrome

NCT01737255 2022-03-31

SIGNIFY

Institute of Cancer Research, United Kingdom

Completed
88 enrolled

Li-Fraumeni Syndrome

NCT01464086 2021-02-25

LIFSCREEN

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed
107 enrolled

Li-Fraumeni Syndrome

NCT02289326 2019-09-19

Biomarker Monitoring in TP53 Mutation Carriers

Scripps Health

Completed
6 enrolled

Neoplastic Syndromes, Hereditary, Li-Fraumeni Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡